DexCom segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di DexCom utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
DXCM | DexCom | $0.45 | $0.57 | — | — | $994.20M | $1.17B | — | — | 10/23/2025 | |
DXCM | DexCom | $0.43 | $0.45 | $0.48 | 6.67% | $1.00B | $1.12B | $1.16B | 3.05% | 07/30/2025 | |
DXCM | DexCom | $0.32 | $0.33 | $0.32 | -3.03% | $921.00M | $1.02B | $1.04B | 1.57% | 05/01/2025 | |
DXCM | DexCom | $0.50 | $0.50 | $0.45 | -10.00% | $1.03B | $1.10B | $1.11B | 1.27% | 02/13/2025 | |
DXCM | DexCom | $0.50 | $0.43 | $0.45 | 4.65% | $975.00M | $990.71M | $994.20M | 0.35% | 10/24/2024 | |
DXCM | DexCom | $0.34 | $0.39 | $0.43 | 10.26% | $871.30M | $1.04B | $1.00B | -3.46% | 07/25/2024 | |
DXCM | DexCom | $0.17 | $0.27 | $0.32 | 18.52% | $741.50M | $909.24M | $921.00M | 1.29% | 04/25/2024 | |
DXCM | DexCom | $0.34 | $0.43 | $0.50 | 16.28% | $815.20M | $1.02B | $1.03B | 1.42% | 02/08/2024 | |
DXCM | DexCom | $0.28 | $0.34 | $0.50 | 47.06% | $769.60M | $939.24M | $975.00M | 3.81% | 10/26/2023 | |
DXCM | DexCom | $0.17 | $0.23 | $0.34 | 47.83% | $692.20M | $841.62M | $871.30M | 3.53% | 07/27/2023 | |
DXCM | DexCom | $0.08 | $0.15 | $0.17 | 13.33% | $628.80M | $720.74M | $741.50M | 2.88% | 04/27/2023 | |
DXCM | DexCom | $0.17 | $0.27 | $0.34 | 25.93% | $698.20M | $809.65M | $815.20M | 0.69% | 02/09/2023 | |
DXCM | DexCom | $0.22 | $0.24 | $0.28 | 16.67% | $650.20M | $751.71M | $769.60M | 2.38% | 10/27/2022 | |
DXCM | DexCom | $0.19 | $0.19 | $0.17 | -10.53% | $595.10M | $698.55M | $692.20M | -0.91% | 07/28/2022 | |
DXCM | DexCom | $0.08 | $0.13 | $0.08 | -38.46% | $505.00M | $623.36M | $628.80M | 0.87% | 04/28/2022 | |
DXCM | DexCom | $0.23 | $0.21 | $0.17 | -19.05% | $568.90M | $695.63M | $698.20M | 0.37% | 02/10/2022 | |
DXCM | DexCom | $0.24 | $0.16 | $0.22 | 37.50% | $500.90M | $617.82M | $650.20M | 5.24% | 10/28/2021 | |
DXCM | DexCom | $0.20 | $0.11 | $0.19 | 72.73% | $451.80M | $551.27M | $595.10M | 7.95% | 07/29/2021 | |
DXCM | DexCom | $0.11 | $0.08 | $0.08 | 0.00% | $405.10M | $484.23M | $505.00M | 4.29% | 04/29/2021 | |
DXCM | DexCom | $0.29 | $0.23 | $0.23 | 0.00% | $462.80M | $552.23M | $568.90M | 3.02% | 02/11/2021 | |
DXCM | DexCom | $0.16 | $0.16 | $0.24 | 50.00% | $396.30M | $476.75M | $500.90M | 5.07% | 10/27/2020 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-07-30 | $0.48 | $0.45 | 6.67 % |
Q1 | 2025-05-01 | $0.32 | $0.33 | -3.03 % |
Q4 | 2025-02-13 | $0.45 | $0.50 | -10.0 % |
Q3 | 2024-10-24 | $0.45 | $0.43 | 4.65 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-07-30 | $1.16B | $1.12B | 3.05 % |
Q1 | 2025-05-01 | $1.04B | $1.02B | 1.57 % |
Q4 | 2025-02-13 | $1.11B | $1.10B | 1.27 % |
Q3 | 2024-10-24 | $994.20M | $990.71M | 0.35 % |
Si prevede che DexCom (DXCM) fornisca risultati il ottobre 23, 2025. Gli ultimi risultati sono stati pubblicati il luglio 30, 2025 per il Q2.
L'EPS effettivo era $0.48, che superato la stima di $0.45.
Le entrate effettive sono state $1.2B, che superato la stima di $1.1B.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.